About Adaptive Phage Therapeutics
Adaptive Phage Therapeutics is a private company based in Gaithersburg, Maryland. It has reported $45,846,387 raised in six offerings on Form D since April 2017. Its chief executive is Gregory Merril.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 25, 2023 | Jun 9, 2023 | $11,999,999of $30.0M target | 4 | $2.9M | EquityRule 506(b) | Form D ↗ |
| May 7, 2021 | May 20, 2021 | $23,262,000of $53.2M target | 59 | $394K | EquityRule 506(b) | Form D ↗ |
| Not yet | Aug 24, 2020amended Aug 27, 2020 | $0of $3.6M target | 0 | — | DebtRule 506(c) | Form D/A ↗1 earlier filing |
| Jun 5, 2020 | Jun 22, 2020 | $2,825,000of $7.0M target | 12 | $235K | DebtRule 506(b) | Form D ↗ |
| Jan 24, 2018 | Jun 5, 2018amended Nov 27, 2019 | $6,994,388of $7.0M target | 40 | $174K | DebtRule 506(b) | Form D/A ↗1 earlier filing |
| Feb 2, 2017 | Apr 14, 2017 | $765,000of $3.0M target | 10 | $76,500 | EquityRule 506(b) | Form D ↗ |
| Total, six offerings | $45,846,387 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Adaptive Phage Therapeutics's Form D filed Jun 9, 2023.
JL
JJ
Jana Jensen
Director
CM
Carl Merril
Director
IH
Ian Hardy
Director
MO
Michael Orndorff
Executive officer
GM
Gregory Merril
Chief Executive Officer and director
JG
Jesse Goodman
Director
RM
Raymond Martz
Director
MH
Martin Heidecker
Director
EL
Evan Loh
Director
SB
Subhendu Basu
Executive officer